0
0
6/19/23 at 12:38pm
Organization
Multiple Sclerosis News Today
38 words
0
Comments
A microRNA called miR-548a-3p may help to identify MS patients who will attain no evidence of disease activity after treatment with Gilenya.
You are the first to view
https://multiplesclerosisnewstoday.com/news-posts/2023/06/19/potential-blood-biomarker-gilenya-response-found-ms-patients/
Create an account
or login to join the discussion